View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Aptar Pharma
2 May 2017

Aptar Pharma and Kali Care Develop Real-Time Medication Management Technology

Aptar Pharma has announced that it entered a partnership with Kali Care in order to address the challenge of monitoring adherence in ophthalmic clinical trials.

The combination of Aptar Pharma’s ophthalmic device expertise and Kali Care’s ground-breaking digital monitoring system for ophthalmic medications is likely to have a significant impact in reducing the costs and complexity of ophthalmic clinical trials.

Silicon Valley-based technology company Kali Care provides a revolutionary sensor technology, which allows clinicians to replace adherence assumptions in clinical trials with collected real-time data. This represents the latest step for Aptar Pharma in the development of drug delivery devices and collaborations in the connected health space.

This strategic collaboration underlines Aptar Pharma’s continuous efforts in breaking new ground in innovative healthcare technologies.

Aptar Pharma’s ability to support complex projects and meet challenging and changing regulatory requirements was recently demonstrated by their collaboration with Allergan on launching the first US Food and Drug Administration (FDA) approved prescription preservative-free ophthalmic multidose product (Restasis MultiDose™).

Aptar Pharma is one of the leading suppliers of aerosol metering valves, a key sub-system of pressurised metered dose inhalers (pDMI) that enables accurate and...
Worth an estimated >2bn in 2009, the nasally administered systemic drugs market has an increasing generics sector, is placing greater emphasis on patient compliance and...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology